Trends in Cardiac Rehabilitation Participation in Patients With Acute Myocardial Infarction: A 5-Year Nationwide Study in Korea Authors: Hyeongsu Kim, Ra Yu Yun, Chul Kim, Yong-Il Shin, Heui Je Bang, Kyeong Eun Uhm, Sung Hea Kim, Jang-Whan Bae, Kunsei Lee, Youngtaek Kim Published: 2025 ABSTRACT AbstractBackgroundCardiac rehabilitation (CR) is a critical secondary prevention strategy for patients with acute myocardial infarction (AMI). Although CR has been covered by the National Health Insurance in Korea since 2017, real-world participation remains suboptimal. We assessed trends in CR participation over the past 5 years and identified factors associated with non-participation in treatment.MethodsThis retrospective observational study analyzed data from the National Health Insurance Service claims database between 2018 and 2022. Patients aged ≥ 40 years who were hospitalized for AMI and received acute-phase interventions, such as thrombolysis, percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG), were included. CR participation was defined as having at least one claim for education, assessment, or treatment services. Multivariable logistic regression was conducted to identify factors associated with non-participation in CR treatment, focusing on patients who received care at CR-providing institutions, to minimize confounding related to institutional availability.ResultsIn total, 109,436 patients were included. Overall participation rates in CR education, assessment, and treatment increased from 2018 to 2022. However, sustained participation in outpatient treatment remained low, with only 5.7% of patients in 2022 completing ≥ 11 treatment sessions. Factors associated with lower treatment participation included the absence of prior education and assessment, lower socioeconomic status, undergoing PCI rather than CABG, and receiving care at non-tertiary hospitals. Regional disparities and inadequate institutional infrastructure further contributed to reduced access to CR services.ConclusionAlthough CR participation among patients with AMI in Korea has gradually increased, treatment continuity remains suboptimal. To enhance CR utilization, policy efforts should prioritize reducing patient burden, addressing provider-level barriers, and promoting equitable access through financial support mechanisms and infrastructure expansion.Keywords: Cardiac Rehabilitation; Myocardial Infarction; Patient Compliance; Insurance, Health; Health Services Accessibility INTRODUCTION Despite the global decline in heart disease-related mortality, ischemic heart disease (IHD) remains the leading cause of disease burden worldwide, with a disability-adjusted life year (DALY) rate of 2,275.9 per 100,000 population in 2022, the highest among all diseases.1 In Korea, heart disease was the second leading cause of death after cancer in 2023, with a mortality rate of 64.8 per 100,000 population. The DALY associated with heart disease in 2020 was 982 per 100,000 population, ranking after diabetes (2,155.8), low back pain (1,750), and ischemic stroke (1,077).2 To mitigate recurrent events, complications, and the substantial socioeconomic burden associated with cardiovascular disease (CVD), the implementation of pharmacological therapies and behavioral interventions, such as smoking cessation, and comprehensive cardiac rehabilitation (CR) is critical. CR represents a multidisciplinary approach designed to stabilize, decelerate, or reverse the progression of CVD.3 According to the British Association for Cardiovascular Prevention and Rehabilitation, CR is defined as, “The coordinated sum of activities required to favorably influence the underlying causes of CVD and to provide the best possible physical, mental, and social conditions, enabling patients, through their own efforts, to preserve or resume optimal functioning within their community and, through improved health behaviors, to slow or reverse the progression of the disease.”4 CR programs can be broadly categorized into two delivery models: center-based cardiac rehabilitation (CBCR), in which patients receive supervised exercise training and education in a hospital or outpatient facility; and home-based cardiac rehabilitation (HBCR), which allows patients to complete rehabilitation activities at home, often supported by remote monitoring and telemedicine technologies. While CBCR is the predominant model in many countries, HBCR has emerged as a promising alternative to improve accessibility, particularly for patients facing geographic or logistical barriers. In total, 111 of 203 countries (54.7%) were reported to offer CR services between 2016 and 2017.5 CR has been associated with reductions in mortality and hospital readmission rates across various cardiac conditions. For instance, in a 10-year follow-up study, Dunlay et al.6 demonstrated that participation in CR following acute myocardial infarction (AMI) was associated with a 25% reduction in hospital readmissions and a 42% reduction in mortality compared with non-participation. Similarly, Pack et al.7 reported that among survivors of coronary artery bypass grafting (CABG), participation in CR was associated with a 46% reduction in 10-year mortality compared with non-participants. CR was introduced in Korea in the late 1990s and has been covered by the National Health Insurance (NHI) system since February 2017. The reimbursed components include CR-related education, assessment, and therapy. Recent studies using NHI claims data have reported participation rates in these educational, assessment, and therapeutic services.8,9 However, these studies were limited by short follow-up durations (1–2 years), lacked data on longitudinal trends in participation, and did not evaluate whether the healthcare institutions visited were adequately equipped to deliver CR services. The lack of comprehensive and long-term data has impeded the development of effective national strategies to improve CR accessibility and continuity, particularly with regard to addressing disparities at the institutional and patient levels across diverse healthcare settings. We generated policy-relevant evidence to support the promotion of CR in Korea by analyzing NHI claims data between 2018 and 2022. In particular, we evaluated whether institutions that treated patients with AMI provided CR education, training, and treatment services, evaluated participation rates in CR, and identified factors associated with non-participation. METHODS Data source and study design We used data from the National Health Insurance Service (NHIS) database, which includes claims submitted by healthcare institutions for services reimbursed under the NHI program. The NHI program covers approximately 97% of the Korean population, while data for the remaining 3%, beneficiaries of the Medical Aid program, are also integrated, ensuring near-complete population coverage. This retrospective observational study was conducted using customized research data provided by the NHIS (NHIS-2025-07-1-115). Our study focused on evaluating participation in CR, including education, assessment, and therapy, during hospitalization and in subsequent outpatient care, among patients newly diagnosed with AMI. Study population We included patients aged ≥ 40 years who were hospitalized for AMI in general hospitals between January 2018 and December 2022. Eligible patients were operationally defined as those admitted through the emergency department with a primary or secondary diagnosis of AMI, identified using International Classification of Diseases, 10th Revision codes I21 or I22, and who received acute-phase treatments during hospitalization, including thrombolysis, percutaneous coronary intervention (PCI), or CABG. The corresponding procedure codes were as follows: thrombolysis (M6634); PCI (M6551, M6552, M6553, M6561, M6562, M6563, M6564, M6565, M6571, M6572, M6638); and CABG (O1640, O1641, O1642, O1647, O1648, O1649, OA640, OA641, OA642, OA647, OA648, OA689). In instances where multiple procedures were claimed, categorization was based on the hierarchy of treatment intensity: CABG was prioritized over PCI, and PCI over thrombolysis. Patients were excluded if they had at least one inpatient or outpatient visit to a clinic-level or higher institution within 1 year prior to the index admission with a diagnosis of angina pectoris (I20), AMI (I21), subsequent myocardial infarction (I22), complications following AMI (I23), other acute IHD (I24), or chronic IHD (I25). Outcome measures and variables Participation in CR education, assessment, and treatment Under the reimbursement policy of the Health Insurance Review and Assessment Service, healthcare facilities that meet specific criteria are eligible to claim reimbursement for providing CR services, including education, assessment, and treatment, to patients with myocardial infarction. Consequently, the identification of specific claims codes for CR education (MM451), assessment (MM452), or treatment (MM453) in the dataset served as the criterion for defining a patient’s participation in the respective CR component. CR participation rates were calculated using two distinct denominators: 1) the total number of eligible patients, and 2) the number of patients who received care at CR-providing institutions, defined as institutions that had submitted at least one CR-related claim. A patient was classified as a CR participant if they had at least one claim for education, assessment, or treatment. Similarly, institutions were classified as CR-providing if they submitted at least one CR-related claim for any included patient. The claim period for CR education was limited to the duration of hospitalization, whereas claims for assessment and treatment were permitted during hospitalization and for up to 1 year following discharge. Additional indicators for CR assessment and treatment participation were defined as follows: i) assessment participation rates stratified by completion of education; ii) frequency of assessment participation, categorized as once, twice, three times, four times, and five times or more; iii) treatment participation rates stratified by participation in education and assessment; and iv) frequency of treatment participation, categorized as once, 2–10 sessions, 11–20 sessions, 21–30 sessions, and ≥ 31 sessions. Finally, the analysis of factors associated with non-participation in CR treatment was restricted to patients who had visited CR-providing institutions during the 5-year study period. Covariates The following variables were included as covariates: sex, age, health insurance premium level, residential region, length of hospital stay, Charlson Comorbidity Index (CCI), and type of healthcare institution. Age was categorized into 10-year intervals (40s, 50s, 60s, 70s, and ≥ 80 years). Health insurance premium level was grouped into five categories: Medical Aid beneficiaries, Grades 1–5, Grades 6–10, Grades 11–15, and Grades 16–20. Residential region was categorized as Seoul, other metropolitan cities (district level), urban areas in provinces (city level), and rural areas (county level). Length of hospital stay was classified as 1–7, 8–14, and ≥ 15 days. The CCI was categorized as 1, 2, and ≥ 3 points. Finally, the types of medical institutions were classified as hospitals, general hospitals, and tertiary general hospitals. Statistical analysis Descriptive statistics were used to summarize the demographic and clinical characteristics of the study population. Subsequently, participation rates in CR education, assessment, and treatment were calculated and presented. To identify independent factors associated with non-participation in CR treatment, a multivariable logistic regression analysis was conducted among patients who visited CR-providing institutions during the 5-year study period. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated for each covariate. Statistical analyses were performed using SAS software (version 7.1; SAS Institute, Cary, NC, USA). Ethics statement The Institutional Review Board (IRB) of Konkuk University (IRB No. 7001355-202408-E-830) approved the study protocol. The requirement for informed consent was waived due to the retrospective nature of the study. All data obtained from the Korean NHIS were fully anonymized prior to analysis. RESULTS General characteristics of the study population In total, 24,151 patients were included in the study in 2018, and 24,452 in 2022. The proportion of male patients was approximately three times greater than that of female patients. By age group, individuals in their 60s, 70s, and 50s accounted for approximately 75% of the study population (Table 1). In terms of health insurance premium levels, Group 4 represented > 30% of participants. Regarding place of residence, approximately 48% of patients resided in urban areas within provinces. Most patients (75–80%) experienced a hospital stay of ≤ 7 days. PCI was the predominant revascularization procedure, performed in > 95% of cases. A CCI score of ≥ 3 was observed in > 95% of the cohort. Furthermore, the vast majority (99%) were admitted to general or tertiary general hospitals. Table 1Baseline characteristics of the study population (2018–2022)Category20182019202020212022Total24,151 (100.0)24,976 (100.0)24,328 (100.0)24,550 (100.0)24,452 (100.0)SexMale18,102 (74.95)18,890 (75.63)18,578 (76.36)18,846 (76.77)18,898 (77.29)Female6,049 (25.05)6,086 (24.37)5,750 (23.64)5,704 (23.23)5,554 (22.71)Age, yr40–492,520 (10.43)2,544 (10.19)2,363 (9.71)2,252 (9.17)2,299 (9.40)50–595,622 (23.28)5,798 (23.21)5,641 (23.19)5,510 (22.44)5,329 (21.79)60–696,434 (26.64)6,703 (26.84)6,821 (28.04)7,163 (29.18)7,131 (29.16)70–795,917 (24.50)6,051 (24.23)5,644 (23.2)5,619 (22.89)5,656 (23.13)≥ 803,658 (15.15)3,880 (15.53)3,859 (15.86)4,006 (16.32)4,037 (16.51)Health insurance premium level1st quintile3,412 (14.13)3,760 (15.05)4,125 (16.96)3,410 (13.89)3,640 (14.89)2nd quintile3,906 (16.17)4,050 (16.22)3,743 (15.39)4,184 (17.04)4,315 (17.65)3rd quintile3,874 (16.04)3,872 (15.5)3,765 (15.48)4,263 (17.36)3,828 (15.66)4th quintile4,803 (19.89)4,890 (19.58)4,488 (18.45)4,852 (19.76)4,907 (20.07)5th quintile8,156 (33.77)8,404 (33.65)8,207 (33.73)7,841 (31.94)7,762 (31.74)RegionSeoul3,720 (15.4)3,771 (15.10)3,576 (14.70)3,500 (14.26)3,683 (15.06)Metropolitan cities (district level)5,891 (24.39)5,929 (23.74)5,814 (23.90)5,897 (24.02)5,928 (24.24)Urban areas in provinces11,313 (46.84)12,033 (48.18)11,808 (48.54)12,016 (48.95)11,770 (48.14)Rural areas in provinces3,227 (13.36)3,243 (12.98)3,130 (12.87)3,137 (12.78)3,071 (12.56)Length of hospital stay, day1–718,692 (77.4)19,383 (77.61)19,391 (79.71)19,473 (79.32)19,565 (80.01)8–143,736 (15.47)3,835 (15.35)3,330 (13.69)3,396 (13.83)3,247 (13.28)≥ 151,723 (7.13)1,758 (7.04)1,607 (6.61)1,681 (6.85)1,640 (6.71)InterventionCABG945 (3.91)967 (3.87)947 (3.89)1,036 (4.22)1,194 (4.88)PCI23,201 (96.07)24,009 (96.13)23,380 (96.1)23,513 (95.78)23,256 (95.11)Thrombolysis5 (0.02)0 (0)1 (0)1 (0)2 (0.01)CCICCI score 12,083 (8.62)2,310 (9.25)2,490 (10.24)2,432 (9.91)2,172 (8.88)CCI score 23,919 (16.23)4,068 (16.29)4,084 (16.79)4,103 (16.71)3,866 (15.81)CCI score ≥ 318,149 (75.15)18,598 (74.46)17,754 (72.98)18,015 (73.38)18,414 (75.31)By type of medical institutionTertiary general hospital9,713 (40.2)9,843 (39.4)9,349 (38.4)9,634 (39.2)9,613 (39.3)General hospital13,545 (56.1)14,300 (57.3)14,212 (58.4)14,135 (57.6)14,215 (58.1)Hospital893 (3.7)833 (3.3)767 (3.2)781 (3.2)624 (2.6)Values are presented as number (%).CABG = coronary artery bypass grafting, PCI = percutaneous coronary intervention, CCI = Charlson Comorbidity Index. Baseline characteristics of the study population (2018–2022) Values are presented as number (%). CABG = coronary artery bypass grafting, PCI = percutaneous coronary intervention, CCI = Charlson Comorbidity Index. Participation rates in CR education, assessment, and treatment Overall participation rates in CR education, assessment, and treatment increased from 3.6%, 8.8%, and 9.0% in 2018 to 5.3%, 11.0%, and 14.9% in 2022, respectively (Table 2). Similarly, the proportion of institutions offering these CR services rose from 14.6%, 42.8%, and 36.8% in 2018 to 18.9%, 50.9%, and 61.1% in 2022. Among patients treated at CR-providing institutions, participation rates improved from 12.9%, 11.9%, and 11.3% in 2018 to 16.4%, 13.4%, and 16.1% in 2022, respectively. Table 2Participation rates in cardiac rehabilitation education, assessment, and treatmentCategory20182019202020212022DenominatorNumerator (%)DenominatorNumerator (%)DenominatorNumerator (%)DenominatorNumerator (%)DenominatorNumerator (%)EducationOverall participation rate24,151877 (3.6)24,976984 (3.9)24,3281,169 (4.8)24,5501,287 (5.2)24,4521,297 (5.3)Proportion of institutions providing education56382 (14.6)57386 (15.0)542105 (19.4)55990 (16.1)529100 (18.9)Utilization rate of institutions providing education24,1516,792 (28.1)24,9766,826 (27.3)24,3286,566 (27.0)24,5506,573 (26.8)24,4527,921 (32.4)Participation in education6,792877 (12.9)6,826984 (14.4)6,5661,169 (17.8)6,5731,287 (19.6)7,9211,297 (16.4)AssessmentOverall participation rate24,1512,114 (8.8)24,9761,637 (6.6)24,3282,562 (10.5)24,5502,592 (10.6)24,4522,689 (11)Proportion of institutions providing assessment563241 (42.8)573169 (29.5)542261 (48.2)559245 (43.8)529269 (50.9)Utilization rate of institutions providing assessment24,15117,787 (73.6)24,97613,671 (54.7)24,32819,221 (79)24,55018,622 (75.9)24,45220,093 (82.2)Participation in assessment17,7872,114 (11.9)13,6711,637 (12.0)19,2212,562 (13.3)18,6222,592 (13.9)20,0932,689 (13.4)Participation in educationWithout education16,9101,707 (10.1)12,6871,327 (10.5)18,0522,063 (11.4)17,3351,988 (11.5)18,7962,105 (11.2)With education877407 (46.4)984310 (31.5)1,169499 (42.7)1,287604 (46.9)1,297584 (45.0)TimingInpatient17,787219 (1.2)13,671234 (1.7)19,221281 (1.5)18,622373 (2.0)20,093318 (1.6)Outpatient17,7871,984 (11.2)13,6711,482 (10.8)19,2212,379 (12.4)18,6222,353 (12.6)20,0932,493 (12.4)FrequencyOnce2,1141,155 (54.6)1,637836 (51.1)2,5621,142 (44.6)2,5921,076 (41.5)2,6891,186 (44.1)Twice2,114420 (19.9)1,637354 (21.6)2,562652 (25.4)2,592634 (24.5)2,689587 (21.8)3times2,114322 (15.2)1,637282 (17.2)2,562464 (18.1)2,592530 (20.4)2,689541 (20.1)4 times2,114124 (5.9)1,637117 (7.1)2,562206 (8.0)2,592225 (8.7)2,689262 (9.7)≥ 5 times2,11493 (4.4)1,63748 (2.9)2,56298 (3.8)2,592127 (4.9)2,689113 (4.2)TreatmentOverall participation rate24,1512,174 (9.0)24,9762,455 (9.8)24,3282,574 (10.6)24,5503,348 (13.6)24,4523,636 (14.9)Proportion of institutions providing treatment563207 (36.8)573213 (37.2)542231 (42.6)559300 (53.7)529323 (61.1)Utilization rate of CR-providing institutions24,15119,166 (79.4)24,97619,786 (79.2)24,32819,933 (81.9)24,55021,947 (89.4)24,45222,557 (92.3)Participation in treatment19,1662,174 (11.3)19,7862,455 (12.4)19,9332,574 (12.9)21,9473,348 (15.3)22,5573,636 (16.1)Participation in education and assessmentNo education, no assessment16,8221,085 (6.4)17,6191,547 (8.8)16,8961,123 (6.6)18,8391,579 (8.4)19,2451,683 (8.7)With education, no assessment41030 (7.3)614114 (18.6)635177 (27.9)649215 (33.1)692260 (37.6)No education, with assessment1,572916 (58.3)1,252648 (51.8)1,9341,074 (55.5)1,9111,274 (66.7)2,0601,379 (66.9)With education and assessment362143 (39.5)301146 (48.5)468200 (42.7)548280 (51.1)560314 (56.1)TimingInpatient19,1661,708 (8.9)19,7861,932 (9.8)19,9332,133 (10.7)21,9472,935 (13.4)22,5573,153 (14.0)Outpatient19,166891 (4.6)19,786983 (5.0)19,933897 (4.5)21,947938 (4.3)22,5571,046 (4.6)FrequencyOnce2,1741,474 (67.8)2,4551,652 (67.3)2,5741,758 (68.3)3,3482,430 (72.6)3,6362,698 (74.2)2–10 sessions2,174523 (24.1)2,455607 (24.7)2,574636 (24.7)3,348728 (21.7)3,636732 (20.1)11–20 sessions2,174110 (5.1)2,455110 (4.5)2,574102 (4.0)3,348104 (3.1)3,636104 (2.9)21–30 sessions2,17429 (1.3)2,45542 (1.7)2,57432 (1.2)3,34839 (1.2)3,63639 (1.1)≥ 31 sessions2,17438 (1.7)2,45544 (1.8)2,57446 (1.8)3,34847 (1.4)3,63663 (1.7) Participation rates in cardiac rehabilitation education, assessment, and treatment The proportion of patients who participated in at least one CR component (education, assessment, or treatment) increased from 17.9% in 2018 to 22.1% in 2022 (Fig. 1). Conversely, the proportion of patients who participated exclusively in education or assessment declined from 6.5% in 2018 to 6.0% in 2022. Annual trends in participation patterns in cardiac rehabilitation components from 2018 to 2022. Edu = education, Assess = assessment, Treat = treatment, All Three = participation in all three components. Participation rates stratified by sex, age, socioeconomic status, residential area, length of hospital stay, revascularization procedure, CCI score, and hospital type (Supplementary Tables 1, 2, 3). Factors associated with non-participation in CR treatment Among 109,436 patients who visited CR-providing institutions during the 5-year study period, treatment participation rates according to key variables are presented in Table 3. Regardless of participation in education sessions, patients who underwent an assessment were more likely to participate in treatment (57.6% and 45.1%, respectively) compared to those who did not (P < 0.001). Males exhibited a higher participation rate (13.4%) than females (P < 0.001). The highest participation rate by age group was observed among those in their 40s (15.0%, P < 0.001). Table 3Factors associated with cardiac rehabilitation treatment participation: univariate and multivariate logistic regression analysesCategoryUnivariate analysis for participationMultivariate analysis for non-participationSubjectsParticipants (%)P OR95% CITotal109,43614,149 (12.9)Participation in education and assessmentNo education, no assessment94,6606,990 (7.4)< 0.00116.8512.06–17.67With education, no assessment3,201795 (24.8)< 0.0013.413.11–3.74No education, with assessment9,1765,283 (57.6)< 0.0011 (reference)1 (reference)With education and assessment2,3991,081 (45.1)< 0.0011 (reference)1 (reference)SexMale83,56311,218 (13.4)< 0.0011 (reference)1 (reference)Female25,8732,931 (11.3)< 0.0010.960.91–1.01Age, yr40–4910,6941,604 (15.0)< 0.0011 (reference)1 (reference)50–5924,8013,502 (14.1)< 0.0011.040.96–1.1260–6930,8064,396 (14.3)< 0.0010.980.91–1.0570–7925,8623,051 (11.8)< 0.0010.990.91–1.07≥ 8017,2731,596 (9.2)< 0.0010.950.87–1.04Health insurance premium levelMedical Aid16,1861,877 (11.6)< 0.0011.121.05–1.20Grade 117,9462,223 (12.4)< 0.0011.11.03–1.16Grade 217,4542,144 (12.3)< 0.0011.131.06–1.21Grade 321,3312,768 (13.0)< 0.0011.091.03–1.15Grade 436,5195,137 (14.1)< 0.0011 (reference)1 (reference)RegionSeoul16,8972,764 (16.4)< 0.0011 (reference)1 (reference)Metropolitan cities (district level)25,7532,687 (10.4)< 0.0012.332.18–2.49Urban areas in provinces52,7117,051 (13.4)< 0.0011.221.15–1.28Rural areas in provinces14,0751,647 (11.7)< 0.0011.561.45–1.68Length of hospital stay, day1–786,09611,279 (13.1)< 0.0011 (reference)1 (reference)8–1415,7451,888 (12.0)< 0.00110.95–1.07≥ 157,595982 (12.9)< 0.0011.040.96–1.13InterventionCABG4,8211,521 (31.5)< 0.0011 (reference)1 (reference)PCI104,60712,627 (12.1)< 0.0014.764.42–5.13Thrombolysis81 (12.5)< 0.0015.440.44–66.70CCICCI score 110,3521,242 (12.0)< 0.0011.121.03–1.21CCI score 217,9702,490 (13.9)< 0.0011 (reference)1 (reference)CCI score ≥ 381,11410,417 (12.8)< 0.0010.980.93–1.04By type of medical institutionTertiary general hospital46,7268,369 (17.9)< 0.0011 (reference)1 (reference)General hospital60,6495,431 (9.0)< 0.0011.811.74–1.89Hospital2,061349 (16.9)< 0.0011.331.16–1.53Results from univariate and multivariate logistic regression analyses are presented as ORs and 95% CIs.OR = odds ratio, CI = confidence interval, CABG = coronary artery bypass grafting, PCI = percutaneous coronary intervention, CCI = Charlson Comorbidity Index. Factors associated with cardiac rehabilitation treatment participation: univariate and multivariate logistic regression analyses Results from univariate and multivariate logistic regression analyses are presented as ORs and 95% CIs. OR = odds ratio, CI = confidence interval, CABG = coronary artery bypass grafting, PCI = percutaneous coronary intervention, CCI = Charlson Comorbidity Index. Participation rates were lower among Medical Aid recipients and those in the lower insurance premium groups (11.6%, 12.4%, and 12.0%, respectively; P < 0.001). Patients residing in Seoul (16.4%) and urban provincial areas (13.4%) demonstrated higher participation rates compared to those in other regions (P < 0.001). Patients hospitalized for ≤ 7 days exhibited a higher participation rate (13.1%, P < 0.001). Among those undergoing revascularization procedures, CABG recipients had the highest participation rate (31.5%, P < 0.001). In addition, patients with a CCI score of 2 exhibited a higher participation rate (13.9%, P < 0.001), as did those treated in tertiary general hospitals (17.9%, P < 0.001). In the multivariable logistic regression analysis, which included variables found to be significant in the univariate analysis, several factors were independently associated with non-participation in CR treatment (Table 3). Compared to patients who received both education and assessment, those who received only education had significantly higher odds of non-participation (OR, 3.41; 95% CI, 3.11–3.74), whereas those who received neither had markedly higher odds (OR, 16.85; 95% CI, 12.06–17.67). Compared to insurance premium Group 4, the odds of non-participation were significantly elevated among Medical Aid beneficiaries (OR, 1.12; 95% CI, 1.05–1.20), Group 1 (OR, 1.10; 95% CI, 1.03–1.16), Group 2 (OR, 1.13; 95% CI, 1.06–1.21), and Group 3 (OR, 1.09; 95% CI, 1.03–1.15). Compared to residents of Seoul, higher odds of non-participation were observed among those living in metropolitan districts (OR, 2.33; 95% CI, 2.18–2.49), urban provincial cities (OR, 1.22; 95% CI, 1.15–1.28), and rural areas (OR, 1.56; 95% CI, 1.45–1.68). When stratified by revascularization procedure, patients who underwent PCI had significantly higher odds of non-participation compared to those who received CABG (OR, 4.76; 95% CI, 4.42–5.13). In terms of comorbidity burden, patients with a CCI score of 1 had higher odds of non-participation compared to those with a score of 2 (OR, 1.12; 95% CI, 1.03–1.21). Finally, compared to those treated at tertiary general hospitals, the odds of non-participation were higher among patients treated at general hospitals (OR, 1.81; 95% CI, 1.74–1.89) and hospitals (OR, 1.33; 95% CI, 1.16–1.53). DISCUSSION We generated policy-relevant evidence to promote CR by presenting participation rates in CR education, assessment, and treatment over the past 5 years among patients with AMI, and by identifying factors associated with non-participation in treatment. An initial notable finding was the increase in the number of medical institutions providing CR services. In particular, the number of institutions offering at least one CR component increased from 82 (14.6%), 241 (42.8%), and 207 (36.8%) in 2018 to 100 (18.9%), 269 (50.9%), and 323 (61.1%) in 2022, respectively. This upward trend reflects a growing institutional willingness to implement CR programs, despite likely variations in service quality. However, a national survey conducted in 2020 reported that only 47 of 164 certified PCI centers (28.7%) fulfilled the minimum requirements for CR delivery, including facility infrastructure, qualified personnel, and essential equipment.10 This finding emphasizes concerns regarding the quality and consistency of CR services and emphasizes the urgent need for standardized evaluation and monitoring mechanisms to ensure effective implementation across institutions. Of the 47 institutions that met the minimum requirements for CR delivery, over 90% provided core components of CR, including education on risk factor management, counseling for medication adherence, cardiopulmonary exercise testing (CPET), and supervised exercise therapy. However, only 17–62% of these institutions offered more comprehensive elements, such as nutritional counseling, psychological assessment, vocational guidance, and stress management, indicating that the scope of CR programs in Korea remains limited.11 Currently, although regional cardiovascular centers in Korea operate under designation and accreditation frameworks, there is no independent accreditation system for CR programs. Existing evaluation criteria for regional centers primarily emphasize operational indicators, such as staffing levels, facility adequacy, follow-up rates, education provision, initiation of early rehabilitation, treatment continuity, and functional assessments.12 However, these criteria do not encompass critical dimensions such as program quality, provider competency, or patient-centeredness. In contrast, the American Association of Cardiovascular and Pulmonary Rehabilitation administers the only international accreditation system for CR programs, which includes comprehensive evaluation of participation rates, program structure, staff qualifications, administrative systems, and quality assurance based on patient outcomes.13 This model promotes program standardization and facilitates greater clinician engagement. Therefore, the introduction of an independent CR accreditation system should be considered. Linking institutional eligibility for reimbursement to the fulfillment of minimum standards in facilities, staffing, and equipment would help ensure that CR services meet baseline quality requirements. Such a system would regulate reimbursement claims and support the delivery of high-quality, evidence-based rehabilitation. We observed a gradual increase in participation in CR education, assessment, and treatment over the study period. Previous studies reported that during the first year of CR reimbursement implementation, the outpatient participation rate in evaluation or treatment following discharge among AMI patients was only 1.5%, and that the inpatient or outpatient CR participation rate, including education, training, or treatment, within the first two years among patients with acute coronary syndrome undergoing PCI or CABG was 5.84%.8,9 In our study, the proportion of patients participating in at least one CR component increased to 17.9% in 2018, with outpatient participation rates for assessment and treatment reaching 12.4% and 4.6%, respectively, by 2022. In comparison, among Medicare beneficiaries aged ≥ 65 years in the United States, the CR participation rate in 2016 was reported to be 24.4%.14 Studies involving cohorts of ≥ 1,000 AMI patients have reported participation rates ranging from 30–61.4%.15,16,17,18,19,20 However, direct comparisons are limited due to variations in inclusion criteria, definitions of CR participation, and measurement methodologies. Although our study demonstrates a positive trend in CR participation among eligible patients, the sustainability of treatment remains suboptimal. The proportion of patients completing ≥ 11 sessions (out of a maximum 36 sessions covered by insurance within 1 year) declined from 8.1% in 2018 to 5.7% in 2022. During this period, many patients may have faced barriers such as concerns over infection risk, limitations in hospital access, and temporary suspension or downsizing of outpatient CR services as healthcare resources were diverted to pandemic response. These pandemic-related disruptions likely contributed to decreased treatment continuity. This persistently low level of sustained outpatient treatment participation suggests that the full therapeutic and preventive potential of CR programs is not being realized. In our study, factors associated with non-participation in CR treatment were classified into patient characteristics (participation in CR education or assessment), economic status (insurance premium level), clinical characteristics (type of revascularization and CCI score), provider-related factors (type of healthcare institution), and system-level determinants (regional disparities). Lower participation rates in education and assessment were associated with reduced engagement in treatment, emphasizing the importance of implementing structured early interventions during hospitalization following acute-phase management. A compensation system should be established to ensure that patients are systematically exposed to CR education and assessment prior to discharge. In real-world clinical practice, however, limited hospitalization durations often constrain the opportunity to conduct comprehensive CR assessments before discharge. To address this challenge, alternative models such as early outpatient assessments or structured post-discharge follow-up visits may facilitate timely CR initiation while accommodating the practical limitations of acute care settings. While claims data do not allow for direct measurement of patient motivation or provider-level barriers, the observed associations with age, socioeconomic status, and hospital type suggest that systemic and logistical factors—such as time constraints, institutional resource limitations, and varying provider engagement—may contribute to non-participation. Moreover, insufficient physician referral may reduce patient engagement, particularly among those who underwent PCI and perceive their condition as less severe. Psychological factors such as anxiety, depression, and lack of motivation, along with opportunity costs related to work, caregiving, and transportation difficulties, may also hinder sustained participation. Despite the inclusion of CR services under NHI coverage, participation remained low among Medical Aid beneficiaries and patients in lower insurance premium tiers, indicating that economic burden continues to pose a significant barrier. This burden extends beyond out-of-pocket expenses to include factors such as travel distance, limited access to transportation, time constraints related to employment or caregiving responsibilities, and opportunity costs, associated with repeated outpatient visits. Notably, under the current reimbursement structure, patients are responsible for 50% of outpatient CR treatment costs, which may further deter participation given the ongoing and repetitive nature of CR programs. In addition, older patients and those with functional limitations may encounter physical barriers to accessing hospital-based services. Limited patient awareness regarding the benefits of CR and insufficient endorsement from primary cardiologists, further exacerbates underutilization.21 Therefore, improving CR participation will require a multifaceted strategy that addresses economic challenges and temporal, physical, and cognitive barriers. Patients who underwent PCI were less likely to participate in CR treatment compared to those who underwent CABG, and those with a CCI score of 1 exhibited lower participation than those with a score of 2. These patterns may reflect patient perceptions regarding the severity of their condition. Considering that PCI is a minimally invasive procedure with a relatively short recovery period, some patients may not recognize the need for ongoing rehabilitation. Therefore, targeted education initiatives should emphasize that CR is a comprehensive, long-term disease management program rather than a service solely focused on physical recovery. In addition, nationwide public campaigns are warranted to raise awareness of the critical role of CR in improving cardiovascular outcomes. From the provider’s perspective, the lower participation rates observed at general hospitals and smaller institutions, compared with tertiary general hospitals, may reflect limited institutional motivation to offer CR services, partly due to low reimbursement rates. The lack of essential infrastructure, such as equipment necessary for CPET and patient monitoring, dedicated spaces for CR, and specialized personnel, further complicates program implementation and operation in smaller institutions.22,23 The current reimbursement system imposes burdens on patients and healthcare providers. For patients, co-payments represent a significant financial barrier despite the relatively low base costs, whereas for providers, inadequate reimbursement rates serve as a disincentive to maintain or expand CR programs. Consequently, the reimbursement structure for CR should be revised to reflect more accurately the operational costs associated with high-quality program delivery. In addition, policy measures, such as designating CR as a special case eligible for reduced co-payment should be considered, enabling patients to access CR services at substantially lower personal expense. At the system level, geographic disparities in the distribution of CR-providing institutions directly affect service accessibility. In total, 14 of the 45 tertiary general hospitals actively offering CR services were located in Seoul between 2021 and 2023, whereas general hospitals and smaller facilities in county-level regions rarely provided CR. This imbalance significantly limits access for rural patients, particularly older adults and individuals with mobility restrictions. Therefore, policy-level infrastructure support is essential to facilitate the establishment of CR programs in regional general hospitals and smaller healthcare facilities. A phased expansion strategy, underpinned by targeted funding, should be implemented to ensure that institutions meet minimum standards for facilities, equipment, and staffing. Furthermore, for patients with lower disease severity or mobility limitations, the implementation of home-based CR models is recommended. Home-based CR can enhance physical accessibility and ensure continuity of care, necessitating the development of a dedicated reimbursement framework. In addition, the integration of digital tools, such as mobile applications and remote monitoring devices, into clinical CR programs, alongside the establishment of appropriate reimbursement policies, should be systematically pursued. These comprehensive efforts are essential to advancing equity and accessibility in CR services. Our study has several limitations. First, the study population was identified using NHI claims data, which inherently limits the accuracy of variables, such as diagnosis codes and CR-related procedure codes. To mitigate this limitation, we restricted the study population to patients who received acute-phase treatment for myocardial infarction at hospital-level institutions and tracked CR-related claims during hospitalization and after discharge. Second, CR participation was operationally defined as the presence of at least one claim for education (MM451), assessment (MM452), or treatment (MM453) services. Although this definition reflects the structural characteristics of the NHI claims data, it introduces several interpretive limitations. For instance, some patients had claims for treatment without corresponding assessment codes, which may indicate one-time treatment provided during hospitalization. As standardized CR programs require the integration of assessment and treatment components, such patterns may suggest deviations from recommended program protocols. Moreover, since CR is ideally delivered as a structured, outpatient-based intervention, brief inpatient sessions may not reflect sustained patient engagement or therapeutic effectiveness. Therefore, the inclusion of inpatient services as indicators of participation may lead to an overestimation of actual participation rates. In addition, the possibility that some institutions submitted CR-related claims despite lacking qualified personnel, appropriate facilities, or necessary equipment cannot be excluded, further limiting the ability to infer clinical implementation solely from administrative data. However, this operational definition has been consistently applied in previous studies using NHIS data, ensuring methodological consistency and facilitating comparability. Third, under the operational guidelines of regional cardiovascular centers, CR education is provided during hospitalization. Therefore, in this study, participation in CR education was defined based on claims submitted during hospitalization. However, in some general and smaller hospitals, CR education is delivered on an outpatient basis. Therefore, this operational definition may have led to an underestimation of actual participation rates in CR education, a limitation that should be considered when interpreting the findings. In conclusion, our study demonstrated that the number of institutions offering CR and the participation of patients with AMI in CR services have increased in Korea over the past 5 years. However, treatment continuity remains suboptimal. Factors associated with non-participation in CR treatment were identified at the patient, provider, and system levels. To enhance CR participation and continuity of care, it is imperative to establish a robust reimbursement and infrastructure framework that enables providers to deliver CR services consistently and effectively. For patients, improving access will require reducing out-of-pocket costs by incorporating CR services into special reimbursement categories and addressing geographical barriers. Potential strategies include transportation support, promotion of home-based CR programs, and the implementation of digital CR platforms. Collectively, these measures can enhance the accessibility and equity of CR services in Korea. Footnotes Disclosure: The authors have no potential conflicts of interest to disclose. Author Contributions: Conceptualization: Kim H.Data curation: Kim H, Lee K.Formal analysis: Kim H, Lee K.Investigation: Shin YI.Methodology: Bang HJ, Uhm KE.Project administration: Bae JW.Resources: Shin YI.Supervision: Kim H, Kim Y.Validation: Bae JW, Kim SH.Visualization: Kim H.Writing - original draft: Yun RY.Writing - review & editing: Kim H, Kim C. Conceptualization: Kim H. Conceptualization: Kim H. Data curation: Kim H, Lee K. Data curation: Kim H, Lee K. Formal analysis: Kim H, Lee K. Formal analysis: Kim H, Lee K. Investigation: Shin YI. Investigation: Shin YI. Methodology: Bang HJ, Uhm KE. Methodology: Bang HJ, Uhm KE. Project administration: Bae JW. Project administration: Bae JW. Resources: Shin YI. Resources: Shin YI. Supervision: Kim H, Kim Y. Supervision: Kim H, Kim Y. Validation: Bae JW, Kim SH. Validation: Bae JW, Kim SH. Visualization: Kim H. Visualization: Kim H. Writing - original draft: Yun RY. Writing - original draft: Yun RY. Writing - review & editing: Kim H, Kim C. Writing - review & editing: Kim H, Kim C. SUPPLEMENTARY MATERIALS Supplementary Table 1 Participation in cardiac rehabilitation education by patient subgroup Supplementary Table 2 Participation in cardiac rehabilitation assessment by patient subgroup Supplementary Table 3 Participation in cardiac rehabilitation treatment by patient subgroup References Associated Data Supplementary Materials Supplementary Table 1 Participation in cardiac rehabilitation education by patient subgroup Supplementary Table 2 Participation in cardiac rehabilitation assessment by patient subgroup Supplementary Table 3 Participation in cardiac rehabilitation treatment by patient subgroup